454 related articles for article (PubMed ID: 26203912)
1. Chemotherapy Use, Performance Status, and Quality of Life at the End of Life.
Prigerson HG; Bao Y; Shah MA; Paulk ME; LeBlanc TW; Schneider BJ; Garrido MM; Reid MC; Berlin DA; Adelson KB; Neugut AI; Maciejewski PK
JAMA Oncol; 2015 Sep; 1(6):778-84. PubMed ID: 26203912
[TBL] [Abstract][Full Text] [Related]
2. Impact of Radiation Therapy on Aggressive Care and Quality of Life Near Death.
Li D; Prigerson HG; Kang J; Maciejewski PK
J Pain Symptom Manage; 2017 Jan; 53(1):25-32. PubMed ID: 27720786
[TBL] [Abstract][Full Text] [Related]
3. Palliative chemotherapy for gastroesophageal cancer in old and very old patients: A retrospective cohort study at the National Center for Tumor Diseases, Heidelberg.
Berger AK; Zschaebitz S; Komander C; Jäger D; Haag GM
World J Gastroenterol; 2015 Apr; 21(16):4911-8. PubMed ID: 25945004
[TBL] [Abstract][Full Text] [Related]
4. Chemotherapy does not improve quality of life in cancer patients at end of life, US study finds.
McCarthy M
BMJ; 2015 Jul; 351():h4139. PubMed ID: 26228874
[No Abstract] [Full Text] [Related]
5. Associations between palliative chemotherapy and adult cancer patients' end of life care and place of death: prospective cohort study.
Wright AA; Zhang B; Keating NL; Weeks JC; Prigerson HG
BMJ; 2014 Mar; 348():g1219. PubMed ID: 24594868
[TBL] [Abstract][Full Text] [Related]
6. Chemotherapy Near the End of Life: First--and Third and Fourth (Line)--Do No Harm.
Blanke CD; Fromme EK
JAMA Oncol; 2015 Sep; 1(6):785-6. PubMed ID: 26203585
[No Abstract] [Full Text] [Related]
7. Provision of spiritual support to patients with advanced cancer by religious communities and associations with medical care at the end of life.
Balboni TA; Balboni M; Enzinger AC; Gallivan K; Paulk ME; Wright A; Steinhauser K; VanderWeele TJ; Prigerson HG
JAMA Intern Med; 2013 Jun; 173(12):1109-17. PubMed ID: 23649656
[TBL] [Abstract][Full Text] [Related]
8. EORTC QLQ-C15-PAL quality of life score as a prognostic indicator of survival in patients with far advanced cancer.
Lee YJ; Suh SY; Choi YS; Shim JY; Seo AR; Choi SE; Ahn HY; Yim E
Support Care Cancer; 2014 Jul; 22(7):1941-8. PubMed ID: 24577883
[TBL] [Abstract][Full Text] [Related]
9. Evaluating Chemotherapy at the End of Life.
Buiting HM; van den Heuvel MM
JAMA Oncol; 2016 Jan; 2(1):143-4. PubMed ID: 26767556
[No Abstract] [Full Text] [Related]
10. Evaluating Chemotherapy at the End of Life.
Provenzano AF; Carvajal RD
JAMA Oncol; 2016 Jan; 2(1):142-3. PubMed ID: 26767555
[No Abstract] [Full Text] [Related]
11. Evaluating Chemotherapy at the End of Life.
Frickhofen N; Maier BO
JAMA Oncol; 2016 Jan; 2(1):142. PubMed ID: 26767554
[No Abstract] [Full Text] [Related]
12. Evaluating Chemotherapy at the End of Life--Reply.
Prigerson HG; Neugut AI; Maciejewski PK
JAMA Oncol; 2016 Jan; 2(1):144. PubMed ID: 26767559
[No Abstract] [Full Text] [Related]
13. Palliative Chemotherapy Near the End of Life in Oncology Patients.
Zhang Z; Chen ML; Gu XL; Liu MH; Zhao WW; Cheng WW
Am J Hosp Palliat Care; 2018 Sep; 35(9):1215-1220. PubMed ID: 29529885
[TBL] [Abstract][Full Text] [Related]
14. Palliative chemotherapy or best supportive care? A prospective study explaining patients' treatment preference and choice.
Koedoot CG; de Haan RJ; Stiggelbout AM; Stalmeier PF; de Graeff A; Bakker PJ; de Haes JC
Br J Cancer; 2003 Dec; 89(12):2219-26. PubMed ID: 14676798
[TBL] [Abstract][Full Text] [Related]
15. Quality-of-Life Evaluation After Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy.
Dodson RM; McQuellon RP; Mogal HD; Duckworth KE; Russell GB; Votanopoulos KI; Shen P; Levine EA
Ann Surg Oncol; 2016 Dec; 23(Suppl 5):772-783. PubMed ID: 27638671
[TBL] [Abstract][Full Text] [Related]
16. Avoiding harmful palliative chemotherapy treatment in the end of life: development of a brief patient-completed questionnaire for routine assessment of performance status.
Näppä U; Lindqvist O; Axelsson B
J Support Oncol; 2012; 10(6):230-7. PubMed ID: 22951048
[TBL] [Abstract][Full Text] [Related]
17. Palliative care team consultation and quality of death and dying in a university hospital: A secondary analysis of a prospective study.
Brinkman-Stoppelenburg A; Witkamp FE; van Zuylen L; van der Rijt CCD; van der Heide A
PLoS One; 2018; 13(8):e0201191. PubMed ID: 30138316
[TBL] [Abstract][Full Text] [Related]
18. Inpatient palliative chemotherapy is associated with high mortality and aggressive end-of-life care in patients with advanced solid tumors and poor performance status.
Fiorin de Vasconcellos V; Rcc Bonadio R; Avanço G; Negrão MV; Pimenta Riechelmann R
BMC Palliat Care; 2019 May; 18(1):42. PubMed ID: 31109330
[TBL] [Abstract][Full Text] [Related]
19. Awareness of incurable cancer status and health-related quality of life among advanced cancer patients: a prospective cohort study.
Lee MK; Baek SK; Kim SY; Heo DS; Yun YH; Park SR; Kim JS
Palliat Med; 2013 Feb; 27(2):144-54. PubMed ID: 22143041
[TBL] [Abstract][Full Text] [Related]
20. The effects of palliative chemotherapy in metastatic colorectal cancer patients with an ECOG performance status of 3 and 4.
Crosara Teixeira M; Marques DF; Ferrari AC; Alves MF; Alex AK; Sabbaga J; Hoff PM; Riechelmann RP
Clin Colorectal Cancer; 2015 Mar; 14(1):52-7. PubMed ID: 25442812
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
